As GlcCer has been proved to have a relationship with chemotherapy resistance in cancers [47], we also investigated the relationship between GBA1-dependent GlcCer reprogramming in the liver cancer cell and sorafenib resistance. The gene discussed is GBA1; the disease is liver cancer.